Insight Molecular Diagnostics Ord Shs
IMDX5.110USD
-0.105-2.01%
Market hours （ET）Quotes delayed by 15 min
146.27MMarket Cap
LossP/E TTM
More Details of Company
Insight Molecular Diagnostics Ord Shs Info
Ticker Symbol- -
Company name- -
IPO date- -
CEO- -
Number of employees- -
Security type- -
Fiscal year-end- -
Address- -
City- -
Stock exchange- -
Country- -
Postal code- -
Phone- -
Website- -
Ticker Symbol- -
IPO date- -
CEO- -
Company Executives of Insight Molecular Diagnostics Ord Shs
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
152.16K
+56.61%
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
39.51K
+776.23%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
36.56K
+2237.85%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.50K
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Andrea S. James
Ms. Andrea S. James
Chief Financial Officer
Chief Financial Officer
--
--
Mr. James Liu, CPA
Mr. James Liu, CPA
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
Principal Accounting Officer, Vice President - Accounting, Controller, Treasurer
--
--
Name
Name/Position
Position
Shareholding
Change
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Chairman of the Board
Chairman of the Board
152.16K
+56.61%
Dr. Andrew J. Last
Dr. Andrew J. Last
Independent Director
Independent Director
39.51K
+776.23%
Mr. Louis E. (Lou) Silverman
Mr. Louis E. (Lou) Silverman
Independent Director
Independent Director
36.56K
+2237.85%
Mr. Joshua Riggs
Mr. Joshua Riggs
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
3.50K
--
Dr. Ekkehard Schuetz, M.D., Ph.D.
Dr. Ekkehard Schuetz, M.D., Ph.D.
Chief Science Officer
Chief Science Officer
--
--
Ms. Andrea S. James
Ms. Andrea S. James
Chief Financial Officer
Chief Financial Officer
--
--
Revenue Breakdown
Currency: USDUpdated: Tue, Dec 9
Currency: USDUpdated: Tue, Dec 9
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2021
FY2020
By BusinessUSD
Name
Revenue
Proportion
Pharma Services
260.00K
0.00%
By RegionUSD
Name
Revenue
Proportion
United States Pharma services
260.00K
100.00%
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Pharma Services
260.00K
0.00%
Shareholding Stats
Updated: Wed, Dec 10
Updated: Wed, Dec 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
39.81%
Smith (Patrick W)
11.37%
AWM Investment Company, Inc.
9.85%
Bio Rad Laboratories Inc
9.64%
Pura Vida Investments, LLC
3.30%
Other
26.03%
Shareholders
Shareholders
Proportion
Broadwood Capital, Inc.
39.81%
Smith (Patrick W)
11.37%
AWM Investment Company, Inc.
9.85%
Bio Rad Laboratories Inc
9.64%
Pura Vida Investments, LLC
3.30%
Other
26.03%
Shareholder Types
Shareholders
Proportion
Hedge Fund
43.49%
Individual Investor
13.08%
Investment Advisor/Hedge Fund
10.89%
Corporation
9.64%
Investment Advisor
2.35%
Other
20.54%
Institutional Shareholding
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q4
59
16.26M
56.74%
-114.47K
2025Q3
63
16.26M
56.74%
-114.67K
2025Q2
76
16.21M
8.76%
+317.02K
2025Q1
86
16.10M
56.30%
+2.27M
2024Q4
89
8.43M
48.30%
-193.34K
2024Q3
99
7.19M
53.72%
-268.68K
2024Q2
118
7.51M
59.43%
+222.34K
2024Q1
152
4.82M
59.90%
+9.71K
2023Q4
161
4.90M
60.95%
-7.78K
2023Q3
177
5.07M
63.04%
-86.38K
View more
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
Broadwood Capital, Inc.
11.41M
39.81%
--
--
Sep 30, 2025
Smith (Patrick W)
3.26M
11.37%
--
--
May 12, 2025
AWM Investment Company, Inc.
2.82M
9.85%
--
--
Sep 30, 2025
Bio Rad Laboratories Inc
2.76M
9.64%
+1.25M
+82.94%
Feb 10, 2025
Pura Vida Investments, LLC
947.13K
3.3%
--
--
Sep 30, 2025
The Vanguard Group, Inc.
486.74K
1.7%
+2.97K
+0.61%
Sep 30, 2025
James (Andrea S.)
151.23K
0.53%
--
--
May 12, 2025
Geode Capital Management, L.L.C.
198.45K
0.69%
+40.87K
+25.94%
Sep 30, 2025
Arno (Andrew)
152.16K
0.53%
+55.00K
+56.61%
Jul 01, 2025
BlackRock Institutional Trust Company, N.A.
85.62K
0.3%
+1.45K
+1.73%
Sep 30, 2025
View more
Related ETFs
Updated: Tue, Dec 9
Updated: Tue, Dec 9
Name
Proportion
iShares Micro-Cap ETF
0.01%
DFA Dimensional US Small Cap Value ETF
0%
Dimensional US Core Equity 1 ETF
0%
iShares Micro-Cap ETF
Proportion0.01%
DFA Dimensional US Small Cap Value ETF
Proportion0%
Dimensional US Core Equity 1 ETF
Proportion0%
Dividend
A total of
0.00
USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
Jul 24, 2023
Merger
20→1
Date
Type
Ratio
Jul 24, 2023
Merger
20→1
FAQs
Who are the top five shareholders of Insight Molecular Diagnostics Ord Shs?
The top five shareholders of Insight Molecular Diagnostics Ord Shs are:
Broadwood Capital, Inc. holds 11.41M shares, accounting for 39.81% of the total shares.
Smith (Patrick W) holds 3.26M shares, accounting for 11.37% of the total shares.
AWM Investment Company, Inc. holds 2.82M shares, accounting for 9.85% of the total shares.
Bio Rad Laboratories Inc holds 2.76M shares, accounting for 9.64% of the total shares.
Pura Vida Investments, LLC holds 947.13K shares, accounting for 3.30% of the total shares.
Broadwood Capital, Inc. holds 11.41M shares, accounting for 39.81% of the total shares.
Smith (Patrick W) holds 3.26M shares, accounting for 11.37% of the total shares.
AWM Investment Company, Inc. holds 2.82M shares, accounting for 9.85% of the total shares.
Bio Rad Laboratories Inc holds 2.76M shares, accounting for 9.64% of the total shares.
Pura Vida Investments, LLC holds 947.13K shares, accounting for 3.30% of the total shares.
What are the top three shareholder types of Insight Molecular Diagnostics Ord Shs?
The top three shareholder types of Insight Molecular Diagnostics Ord Shs are:
Broadwood Capital, Inc.
Smith (Patrick W)
AWM Investment Company, Inc.
Broadwood Capital, Inc.
Smith (Patrick W)
AWM Investment Company, Inc.
How many institutions hold shares of Insight Molecular Diagnostics Ord Shs (IMDX)?
As of 2025Q4, 59 institutions hold shares of Insight Molecular Diagnostics Ord Shs, with a combined market value of approximately 16.26M, accounting for 56.74% of the total shares. Compared to 2025Q3, institutional shareholding has increased by 0.00%.
What is the biggest source of revenue for Insight Molecular Diagnostics Ord Shs?
In FY2025Q3, the Pharma Services business generated the highest revenue for Insight Molecular Diagnostics Ord Shs, amounting to 260.00K and accounting for --% of total revenue.
